control efforts to protect the figh...
control efforts to protect the fights and safety of participants in clinical trials are focusing more attention upon the activities and characters of institutional review boards. Increased funding of research by means of the National Institutes of Health and by means of the pharmaceutical industry continues to expand IRB work loads. modern government policies are adding to these assignments. of that kind developments raise concerns about the ability of these panels to provide timely and informed review of research programs. The Department of Health and Human Services (HHS) is responding with more guidance to
|